XCEL Capsules, 300 mg, 60-count bottles, Manufactured for JNS Health
Publicado el 13 de julio de 2016 · Inicio del retiro: 15 de diciembre de 2015
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared fluoxetine, an FDA approved drug used to treat depression, anxiety, panic attacks, obsessive-compulsive disorder, or bulimia and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Detalles del retiro
- Fabricante
- Bee Extremely Amazed LLC
- Distribuidor
- Nationwide
- Lote
- All lots
- Clasificación de riesgo
- Class I
- Área (FDA)
- drug
- País
- United States